We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
-15.59%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$372M
AUM Growth
+$629K
Cap. Flow
+$55.3M
Cap. Flow %
14.88%
Top 10 Hldgs %
7.49%
Holding
1,005
New
327
Increased
192
Reduced
135
Closed
351

Top Buys

Rank Stock Value
1
DOV icon
Dover
DOV
+$4.83M
2
VIRT icon
Virtu Financial
VIRT
+$4.26M
3
SYK icon
Stryker
SYK
+$3.04M
4
BG icon
Bunge Global
BG
+$3.04M
5
TU icon
Telus
TU
+$2.88M

Sector Composition

Rank Sector Weight
1 Industrials 15.53%
2 Healthcare 15.46%
3 Financials 14.04%
4 Technology 12.18%
5 Consumer Discretionary 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WB icon
26
Weibo
WB
$1.96B
$1.55M 0.42%
67,236
+53,736
+398% +$1.2M
MKTX icon
27
MarketAxess Holdings
MKTX
$5.72B
$1.54M 0.41%
+6,016
New +$1.65M
VLY icon
28
Valley National Bancorp
VLY
$8.1B
$1.51M 0.41%
+145,303
New +$1.73M
MDRX
29
DELISTED
Veradigm Inc. Common Stock
MDRX
$1.49M 0.4%
100,246
+68,151
+212% +$1.27M
CG icon
30
Carlyle Group
CG
$17.2B
$1.45M 0.39%
+45,806
New +$1.76M
HELE icon
31
Helen of Troy
HELE
$680M
$1.43M 0.39%
+8,812
New +$1.66M
HCA icon
32
HCA Healthcare
HCA
$89.6B
$1.41M 0.38%
8,360
+3,941
+89% +$847K
BNS icon
33
Scotiabank
BNS
$108B
$1.4M 0.38%
+23,649
New +$1.53M
TAC icon
34
TransAlta
TAC
$3.88B
$1.4M 0.38%
+122,797
New +$1.35M
EFOR
35
Everforth Inc
EFOR
$1.33B
$1.37M 0.37%
+15,193
New +$1.56M
IMXI icon
36
International Money Express
IMXI
$356M
$1.37M 0.37%
66,800
+5,536
+9% +$111K
CFR icon
37
Cullen/Frost Bankers
CFR
$10.3B
$1.32M 0.36%
+11,325
New +$1.45M
SLCA
38
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$1.32M 0.35%
+115,441
New +$1.94M
BJ icon
39
BJs Wholesale Club
BJ
$12.3B
$1.31M 0.35%
21,015
+103
+0.5% +$6.47K
KEY icon
40
KeyCorp
KEY
$24.3B
$1.3M 0.35%
+75,343
New +$1.46M
BC icon
41
Brunswick
BC
$5.21B
$1.28M 0.34%
+19,569
New +$1.44M
TBI
42
Trueblue
TBI
$323M
$1.26M 0.34%
+70,399
New +$1.65M
PCRX icon
43
Pacira BioSciences
PCRX
$974M
$1.25M 0.34%
+21,511
New +$1.41M
FCN icon
44
FTI Consulting
FCN
$4.17B
$1.25M 0.34%
+6,930
New +$1.14M
ETN icon
45
Eaton
ETN
$173B
$1.25M 0.34%
+9,914
New +$1.39M
DLX icon
46
Deluxe
DLX
$1.12B
$1.23M 0.33%
+56,698
New +$1.44M
LII icon
47
Lennox International
LII
$14.6B
$1.22M 0.33%
+5,883
New +$1.29M
WST icon
48
West Pharmaceutical
WST
$24.8B
$1.22M 0.33%
4,017
+3,490
+662% +$1.14M
CCRN
49
DELISTED
Cross Country Healthcare
CCRN
$1.21M 0.33%
58,128
+17,704
+44% +$332K
CLS icon
50
Celestica
CLS
$39.7B
$1.19M 0.32%
122,612
+30,645
+33% +$329K

Similar funds

Campbell & Co Investment Adviser's Q2 2022 Portfolio in Review

As of Q2 2022, Campbell & Co Investment Adviser held 1,005 positions worth $372M, up 0.17% from $371M the previous quarter. Its ten largest holdings account for 7.5% of the portfolio.

Campbell & Co Investment Adviser deployed $55.3M of net new capital in Q2 2022, opening 327 new positions and adding to 192 existing holdings. Its largest new stake was Dover: 35,715 shares worth $4.33M.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was CONTINENTAL RESOURCES INC., an estimated $2.72M trimmed.

  • Campbell & Co Investment Adviser's largest Q2 2022 buy was Dover: 35,715 shares worth $4.33M.
  • Campbell & Co Investment Adviser added most to Bunge Global in Q2 2022, an estimated $3.04M increase.
  • Campbell & Co Investment Adviser's biggest Q2 2022 reduction was CONTINENTAL RESOURCES INC., cutting an estimated $2.72M.
  • Campbell & Co Investment Adviser fully exited Costco in Q2 2022, selling an estimated $2.85M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 7.5% of its $372M portfolio in Q2 2022.
  • Campbell & Co Investment Adviser opened 327 new positions and closed 351 in Q2 2022.
  • Campbell & Co Investment Adviser's portfolio value rose 0.17% quarter-over-quarter to $372M.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2022, filed 9 Aug 2022.